Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting Date
Yahoo FinanceFeb 27 08:31 ET
Sector Update: Financial Stocks Ease Late Afternoon
Financial stocks were declining in late Monday afternoon trading, with the NYSE Financial Index shedding 0.7% and the Financial Select Sector SPDR Fund (XLF) down 0.4%. The Philadelphia Housing Index
MT NewswiresFeb 5 15:48 ET
Sector Update: Financial
Financial stocks were decreasing in late Monday afternoon trading, with the NYSE Financial Index decreasing 0.7% and the Financial Select Sector SPDR Fund (XLF) dropping 0.4%. The Philadelphia Housing
MT NewswiresFeb 5 15:25 ET
Nocturne Acquisition Shares Jump as Stockholders' Vote on Merger With Cognos Therapeutics Postponed Further
Nocturne Acquisition (MBTC) shares rose 9.9% in recent Monday trading after the special purpose acquisition company said its board further postponed an extraordinary shareholders' meeting to vote on t
MT NewswiresFeb 5 14:12 ET
Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting
SANTA ANA, CA / ACCESSWIRE / January 30, 2024 / Nocturne Acquisition Corp. , announced today that the Board of Directors has voted in favor of postponing the meeting date for the
AccesswireJan 30 08:31 ET
Express News | Nocturne Acquisition Says Co Intends To Approve Extension Of Date By Which Co Must Consummate Initial Business Combination By One Month To Jan 5, 2024
Moomoo 24/7Nov 28, 2023 15:33 ET
Express News | Nocturne Acquisition And Cognos Therapeutics Secure Chardan As Capital Markets Advisor For Business Combination
Moomoo 24/7Sep 21, 2023 01:39 ET
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination With Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR)) ("Nocturne") and Cognos Therapeutics, Inc. ("Cognos") today announced the
GlobeNewswireSep 20, 2023 18:35 ET
Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection With Its Proposed Business Combination With Cognos
Transaction Expected to Accelerate the Research and Advancement of Cognos' Proprietary and Innovative Implantable Drug Delivery Pump to Improve Outcomes for Treatment of Brain Cancers and Other Neurological
AccesswireAug 16, 2023 08:05 ET
Nocturne Acquisition Corporation Announces Receipt of a Second Notification From Nasdaq
WILMINGTON, DE / ACCESSWIRE / May 30, 2023 / Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (the "Company", "MBTC"), today announced that it has received a second notification (the "Seco
AccesswireMay 30, 2023 08:30 ET
Mobile TeleSystems GAAP EPS of RUB7.42, Revenue of RUB139.6B
Seeking AlphaMay 19, 2023 16:24 ET
Short Interest in Nocturne Acquisition Co. (NASDAQ:MBTC) Rises By 5.6%
Nocturne Acquisition Co. (NASDAQ:MBTC – Get Rating) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 11
Financial News LiveMar 18, 2023 03:41 ET
Nocturne Acquisition Co. (NASDAQ:MBTC) Short Interest Update
Nocturne Acquisition Co. (NASDAQ:MBTC – Get Rating) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 6,000 shares,
Financial News LiveJan 26, 2023 20:44 ET
Nocturne Acquisition Co. (NASDAQ:MBTC) Sees Significant Drop in Short Interest
Nocturne Acquisition Co. (NASDAQ:MBTC – Get Rating) was the target of a significant decrease in short interest in December. As of December 30th, there was short interest totalling 2,200 shares, a de
kopsourceJan 21, 2023 00:51 ET
Nocturne Acquisition (NASDAQ:MBTC) Trading Up 0.3%
Shares of Nocturne Acquisition Co. (NASDAQ:MBTC – Get Rating) traded up 0.3% on Monday . The company traded as high as $10.68 and last traded at $10.66. 4,930 shares traded hands during mid-day tradi
Defense WorldJan 10, 2023 02:31 ET
Nocturne Acquisition in Deal to Merge With Cognos Therapeutics
10:40 AM EST, 01/03/2023 (MT Newswires) -- Nocturne Acquisition Corp. (MBTC) said Tuesday it will merge with medical technology company Cognos Therapeutics in an all-stock deal, and plans to list the
MT NewswiresJan 3, 2023 10:42 ET
Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination With Nocturne Acquisition Corporation
Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenera
AccesswireJan 3, 2023 08:32 ET
Nocturne Acquisition Co. (NASDAQ:MBTC) Sees Significant Growth in Short Interest
Nocturne Acquisition Co. (NASDAQ:MBTC – Get Rating) was the target of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 3,000 sh
kopsourceDec 18, 2022 06:22 ET
BRIEF-Nocturne Acquisition Corp Confirms Funding To Extend Period To Consummate Initial Business Combination
April 5 (Reuters) - Nocturne Acquisition Corp MBTC.O :* NOCTURNE ACQUISITION CORP. CONFIRMS FUNDING TO EXTEND PERIOD TO CONSUMMATE INITIAL BUSINESS COMBINATION* NOCTURNE ACQUISITION - $1.15 MILLION H
reutersApr 5, 2022 18:26 ET
Nocturne Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination
WILMINGTON, DE / ACCESSWIRE / April 5, 2022 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that an aggregate of $1,150,000 (the "Extension Payment") has been deposited in
AccesswireApr 5, 2022 16:06 ET
No Data
No Data